TickerGuard
Buy Day today: Poor (52) Mixed market breadth · today: Core PCE (August) ≈
COYA

Coya Therapeutics, Inc.

Healthcare · Biotechnology

5.20$ +2.8% vs. previous close Closing price · As of: Sep 24, 2026

Statements

Balance Sheet

All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.

Tick rows to compare them in a chart (up to 4)

Balance Sheet COYA
Line item 2020 2021 2022 2023 2024 2025
– -45.2% +75.2% +391.5% +7.5% +12.6%
– -47.6% +56.7% +473.4% +7.6% +12.7%
– -50.2% +36.7% +449.9% +17.5% +22.1%
– -50.2% +36.7% +449.9% +17.5% +22.1%
– – – – -90.3% –
– – -22.7% – – –
– +156.8% +1,362.0% -66.5% -15.2% +45.1%
– +156.8% +233.0% +32.1% -24.3% +53.5%
– – – – – –
– +91.8% +111.7% -36.3% +37.4% -33.2%
– – – – – –
– -56.1% -330.4% – +11.1% +8.7%
– – – – – –
– +154.9% +50.7% +2.2% +49.9% +9.8%

Data as of: September 24, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?